Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
CytomX Therapeutics Inc
Swot
CytomX Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
CytomX Therapeutics Inc has 12 Strengths, 6 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(12)
Weakness
(6)
Opportunity
(3)
Threats
(1)
Others
(2)
High Normalized Momentum Score
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over Half Year (6 Months)
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
Highest Recovery from 52 Week Low
Stocks with Quarter Change % less than Industry
PE higher than Industry PE
Top Losers
Profit to Loss Companies
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mutual Funds Decreased Shareholding in Past Month
Promoters increasing shareholding QoQ
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
